Studying Tumor-ReacTive T Cells: A Personalized Organoid Model

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Personalized cancer immunotherapies require effective methods to study patient-specific anti-tumor immune responses.
• Current methods may not fully capture the complexity of the tumor microenvironment and T cell interactions.

Purpose of the Study:

• To introduce and validate a novel tumor organoid/lymphocyte co-culture platform.
• To enable the expansion and analysis of tumor-specific T cell responses in a patient-specific manner.

Main Methods:

• Development of a co-culture system combining patient-derived tumor organoids with autologous lymphocytes.
• Expansion of tumor-specific T cells within the co-culture environment.
• Analysis of T cell responses, including functionality and specificity.

Main Results:

• Successful expansion of tumor-specific T cells from epithelial cancer samples.
• Demonstration of patient-specific T cell responses against tumor targets.
• Validation of the platform's applicability for analyzing immune responses in the tumor microenvironment.

Conclusions:

• The tumor organoid/lymphocyte co-culture platform provides a robust model for studying patient-specific T cell immunity.
• This approach holds significant potential for the clinical translation of novel personalized immunotherapies for epithelial cancers.